Biotricity Inc. (BTCY) stock
BTCYOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$0.05+0.00 (+8.70%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Biotricity EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Biotricity's EPS for the twelve months ending Jun 30, 2026 was -$0.14. For fiscal 2026 it was -$0.12. The highest annual figure on record is -$0.12 in fiscal 2026.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$0.12 | – |
| FY2025 | Mar 31, 2025 | -$0.56 | – |
| FY2024 | Mar 31, 2024 | -$1.66 | – |
| FY2023 | Mar 31, 2023 | -$2.26 | – |
| FY2021 | Mar 31, 2021 | -$2.63 | – |
| FY2020 | Mar 31, 2020 | -$1.89 | – |
| FY2019 | Mar 31, 2019 | -$1.54 | – |
| FY2018 | Mar 31, 2018 | -$1.72 | – |
| FY2014 | Aug 31, 2014 | -$0.12 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -$0.05 | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | -$0.02 | – |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | -$0.04 | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -$0.03 | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$0.03 | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$0.05 | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$0.07 | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$0.49 | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$0.47 | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$0.34 | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -$0.44 | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$0.41 | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$0.56 | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$0.55 | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$0.71 | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$0.89 | – |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | -$1.54 | – |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$0.91 | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -$0.89 | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -$0.67 | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | -$0.51 | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$0.55 | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$0.80 | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -$0.40 | -196.6% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | -$0.34 | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$0.36 | – |
| Q1 FY2019CQ2 2018 | Dec 31, 2018 | -$1.24 | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $0.41 | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -$0.63 | – |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | -$0.41 | – |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | -$0.29 | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | -$0.50 | – |
| Q4 FY2014CQ3 2014 | Aug 31, 2014 | -$0.03 | – |
| Q3 FY2014CQ2 2014 | May 31, 2014 | $0.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?